Symbio is a research-led API manufacturer redefining global pharma partnerships through innovative chemistry, sustainable processes, and an expanding CDMO platform built for scale, science, and trust.
Our state-of-the-art R&D centre in Bangalore is at the heart of Symbio’s business - where science, sustainability, and scale converge to design next-generation processes.
Symbio operates three fully integrated API manufacturing facilities - one in Vizag and two near Bangalore - engineered for regulatory excellence, process efficiency, and sustainable scalability.
Through deep chemistry and intelligent process design, Symbio transforms complexity into scalable, sustainable success. With a strong foundation, established facilities, and proven delivery experience, we help our partners accelerate the journey from concept to commercialization.
Symbio partners with leading pharmaceutical companies across 40+ countries, delivering trusted APIs and pharmaceutical enzymes to markets spanning from Europe to Korea, Turkey, Brazil, and other key markets.
With a strong regulatory foundation - including WHO-GMP, ANVISA, and CEP approvals, and USFDA/EU-GMP readiness - we ensure seamless global supply, consistent quality, and compliance
Symbio delivers high-quality APIs and pharmaceutical enzymes through research-led, sustainable, and collaborative manufacturing built for both today’s and tomorrow’s markets.
Corporate Social Responsibility.
Symbio’s Corporate Social Responsibility philosophy is to make a meaningful and measurable impact in the lives of economically and socially challenged communities of the country.
For the year 2022, we are investing our resources in the field of education for underprivileged students. We have partnered with 2 organizations who are doing meaningful work in the space: Bhumi and Team Everest.
Read More